Does Aimovig Interact with Common Migraine Drugs?
Aimovig (erenumab) has no major drug interactions with most standard migraine medications, including triptans (like sumatriptan), NSAIDs (like ibuprofen), acetaminophen, beta-blockers (like propranolol), anticonvulsants (like topiramate), or antidepressants (like amitriptyline). Clinical trials and post-marketing data show it can be used alongside these without significant pharmacokinetic changes, as Aimovig targets the CGRP receptor without broadly affecting liver enzymes like CYP450.[1][2]
What About Over-the-Counter Pain Relievers?
Safe to combine with OTC options such as ibuprofen, naproxen, or aspirin. No increased risk of gastrointestinal issues or reduced efficacy reported in studies.[1]
Risks with Other CGRP-Targeted Migranes?
Combining Aimovig with other CGRP blockers like Nurtec (rimegepant), Ubrelvy (ubrogepant), or Emgality (galcanezumab) is not recommended. These share the same pathway, potentially leading to excessive blockade without added benefit and unknown long-term effects. FDA labeling advises against concurrent use.[2][3]
Any Concerns with Opioids or Botox?
No direct interactions with short-term opioids (like codeine) or Botox (onabotulinumtoxinA) for chronic migraine. Both are often used together in practice, with trials supporting additive effects.[1][4]
What Do Real-World Studies and Patient Reports Show?
Real-world evidence from registries like the AIMOVIG Pregnancy Registry and pharmacovigilance data confirms low interaction rates. Common side effects (constipation, injection-site reactions) don't worsen with polytherapy. Patients on multiple preventives report similar tolerability.[2][5] Always monitor blood pressure, as Aimovig can cause mild hypertension independently.
When Should You Talk to a Doctor?
Consult a provider before starting, especially if you have cardiovascular risks or take strong CYP3A4 inhibitors (rare in migraine regimens). No routine lab monitoring needed, but disclose full med list.[3]
[1]: FDA Aimovig Prescribing Information (https://www.accessdata.fda.gov/drugsatfdadocs/label/2023/761032s019lbl.pdf)
[2]: Amgen Safety Profile (https://www.aimovig.com/)
[3]: Drugs.com Interaction Checker (https://www.drugs.com/druginteractions.html)
[4]: American Headache Society Guidelines (https://americanheadachesociety.org/wp-content/uploads/2021/03/AHS-Consensus-Statement-Preventive-Treatment.pdf)
[5]: PubMed Review on CGRP Monoclonal Antibodies (https://pubmed.ncbi.nlm.nih.gov/34758158/)